S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. by Matthew J. Frank, John Baird, Anne Kramer, Shabnum Patel, Bita Sahaf, Juliana Craig, Emma Crawford, Sheren Younes, Jean Oak, Yasodha Natkunan, Jay Spiegel, Zachary Ehlinger, Harshini Chinnasamy, Warren Reynolds, Hrishi Srinagesh, Yi-Jiun Su, Emily Egeler, Steven Feldman, Crystal Mackall, Lori Muffly, David Miklos

Get full text